US4595061015 - Common Stock

Overall **IFF** gets a fundamental rating of **3** out of 10. We evaluated **IFF** against 85 industry peers in the **Chemicals** industry. **IFF** may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, **IFF** is valued expensive at the moment.

In the past year **IFF** had a positive cash flow from operations.

In multiple years **IFF** reported negative net income over the last 5 years.

With a **Return On Invested Capital** value of **1.58%**, **IFF** is not doing good in the industry: **69.41%** of the companies in the same industry are doing better.

The **Average Return On Invested Capital** over the past 3 years for **IFF** is below the industry average of **7.57%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.05% | ||

ROE | 0.1% | ||

ROIC | 1.58% |

ROA(3y)-0.64%

ROA(5y)0.81%

ROE(3y)-1.2%

ROE(5y)1.84%

ROIC(3y)2.64%

ROIC(5y)3.31%

In the last couple of years the **Operating Margin** of **IFF** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 5.14% | ||

PM (TTM) | 0.15% | ||

GM | 31.76% |

OM growth 3Y-14.54%

OM growth 5Y-12.87%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.72%

GM growth 5Y-5.08%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **IFF** is destroying value.

Looking at the **Altman-Z score**, with a value of **1.24**, **IFF** is doing worse than **70.59%** of the companies in the same industry.

With a **Debt to Equity ratio** value of **0.54**, **IFF** perfoms like the industry average, outperforming **55.29%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.54 | ||

Debt/FCF | 22.74 | ||

Altman-Z | 1.24 |

ROIC/WACC0.23

WACC6.81%

A Quick Ratio of **1.04** indicates that **IFF** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.74 | ||

Quick Ratio | 1.04 |

The earnings per share for **IFF** have decreased strongly by **-36.91%** in the last year.

The **Earnings Per Share** has been decreasing by **-1.15%** on average over the past years.

Measured over the past years, **IFF** shows a very strong growth in **Revenue**. The Revenue has been growing by **29.63%** on average per year.

EPS 1Y (TTM)-36.91%

EPS 3Y-3.41%

EPS 5Y-1.15%

EPS growth Q2Q-34.56%

Revenue 1Y (TTM)-7.97%

Revenue growth 3Y34.26%

Revenue growth 5Y29.63%

Revenue growth Q2Q-7.93%

Based on estimates for the next years, **IFF** will show a small growth in **Revenue**. The Revenue will grow by **1.42%** on average per year.

EPS Next Y-38.7%

EPS Next 2Y-14.17%

EPS Next 3Y-5.01%

EPS Next 5Y1.86%

Revenue Next Year-8.08%

Revenue Next 2Y-4.36%

Revenue Next 3Y-1.55%

Revenue Next 5Y1.42%

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The **Price/Earnings** ratio is **21.38**, which indicates a rather expensive current valuation of **IFF**.

The rest of the industry has a similar **Price/Earnings** ratio as **IFF**.

The average S&P500 **Price/Earnings** ratio is at **26.00**. **IFF** is around the same levels.

The **Price/Forward Earnings** ratio is **18.74**, which indicates a rather expensive current valuation of **IFF**.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **21.38**, **IFF** is valued at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 21.38 | ||

Fwd PE | 18.74 |

Based on the **Enterprise Value to EBITDA** ratio, **IFF** is valued a bit more expensive than 62.35% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 43.26 | ||

EV/EBITDA | 16.88 |

A cheap valuation may be justified as **IFF**'s earnings are expected to decrease with **-5.01%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-14.17%

EPS Next 3Y-5.01%

With a **Yearly Dividend Yield** of **3.95%**, **IFF** has a reasonable but not impressive dividend return.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.95% |

The dividend of **IFF** has a limited annual growth rate of **4.02%**.

Dividend Growth(5Y)4.02%

Div Incr Years20

Div Non Decr Years20

The dividend of **IFF** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP4852.94%

EPS Next 2Y-14.17%

EPS Next 3Y-5.01%

**INTL FLAVORS & FRAGRANCES**

NYSE:IFF (2/22/2024, 10:31:04 AM)

**76.765**

**-0.02 (-0.02%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap19.60B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.95% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 21.38 | ||

Fwd PE | 18.74 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.05% | ||

ROE | 0.1% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 5.14% | ||

PM (TTM) | 0.15% | ||

GM | 31.76% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.35

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.54 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.74 | ||

Quick Ratio | 1.04 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-36.91%

EPS 3Y-3.41%

EPS 5Y

EPS growth Q2Q

EPS Next Y-38.7%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-7.97%

Revenue growth 3Y34.26%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y